VacA seropositivity is not associated with the development of gastric cancer in a Japanese population

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue 8, 1999, Pages 887-890

  Shimoyama, Tadashi ^a,b   Neelam, Beena ^a   Fukuda, Shinsaku ^b   Tanaka, Masanori ^b   Munakata, Akihiro ^b   Crabtree, Jean E ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

Gastric cancer; Helicobacter pylori; VacA

Indexed keywords

CYTOTOXIN; IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; HELICOBACTER PYLORI; HUMAN; INTESTINE CANCER; JAPAN; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SEROPREVALENCE; STOMACH CANCER; WESTERN BLOTTING;

ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL TOXINS; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; JAPAN; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SEROLOGIC TESTS; STOMACH NEOPLASMS;

EID: 0032772726     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199908000-00013     Document Type: Article

References (26)

1. 1 The Eurogast Study Group. An international association between Helicobacter pylori and gastric cancer. Lancet 1993; 341:1359-1362.
2. 2 Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orenteich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325:1127-1131.
3. 3 Nomura A, Stemmermann GN, Chyou P, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma in a population of Japanese-Americans in Hawaii. N Engl J Med 1991; 325:1132-1136.
4. 4 Forman D, Newell DG, Fullerton F, Yarnell JGW, Stacey AR, Wald N, et al. Association between infection with Helicobacter pylori infection and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991; 302:1302-1305.
5. 5 Taylor DN, Blaser MJ. The epidemiology of Helicobacter pylori infection. Epidemiol Rev 1991; 13:42-59.
6. 6 Cover TL, Dooley C, Blaser MJ. Characterisation and human response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 1990; 58:603-610.
7. 7 Telford JL, Ghiara P, Dell'Oco M, Comanducci M, Burroni D, Bugnoli M, et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 1992; 179: 1653-1658.
8. 8 Fox JG, Correa P, Taylor NS, Thompson N, Fontham E, Janney F, et al. High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis. Am J Gastroenterol 1992; 87:1554-1560.
9. 9 Maeda S, Ogura K, Yoshida H, Kanai F, Ikenoue T, Kato N, et al. Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut 1998; 42:338-343.
10. 10 Ito S, Azuma T, Murakita H, Hiarai M, Miyaji H, Ito Y, et al. Profile of Helicobacter pylori cytotoxin derived from two areas of Japan with different prevalence of atrophic gastritis. Gut 1996; 39:800-806.
11. 11 Cover TL, Cao P, Murthy UK, Sipple S, Blaser MJ. Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori. J Clin Invest 1992; 90:913-918.
12. 12 Rudi J, Kolb C, Maiwald M, Zuna I, von Herbay A, Galle PR, et al. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Dig Dis Sci 1997; 42:1652-1659.
13. 13 Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969; 1:87-97.
14. 14 Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965; 64:31-49.
15. 15 Kodama A, Inokuchi K, Soejima K, Matsusaka T, Okomura T. Growth patterns and prognosis in early gastric carcinoma. Cancer 1983; 51:320-326.
16. 16 Neelam B, Davies G, Wyatt JI, Crabtree JE. Evaluation of a new immunoblot assay using recombinant proteins for the detection of antibodies to Helicobacter pylori [Abstract]. Gut 1998; 42 (suppl 1):A81.
17. 17 Figura N, Guglielmetti P, Rossolini A, Barberi A, Cusi G, Musmanno RA, et al. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol 1989; 27:225-226.
18. 18 Hirai M, Azuma T, Ito S, Kato T, Kohli Y, Fujiki N. High prevalence of neutralizing activity of Helicobacter pylori cytotoxin in serum of gastric-carcinoma patients. Int J Cancer 1994; 56:56-60.
19. 19 Ogura K, Kanai F, Maeda S, Yoshida H, Ogura M, Lan KH, et al. High prevalence of cytotoxin positive Helicobacter pylori in patients unrelated to the presence of peptic ulcers in Japan. Gut 1997; 41:463-468.
20. 20 Atherton JC, Cao P, Peek RM, Tummuru MKR, Blase MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. J Biol Chem 1995; 270:17771-17777.
21. 21 Basso D, Navaglia F, Brigato L, Piva MG, Toma A, Greco E, et al. Analysis of Helicobacter pylori vacA and cagA genotypes and serum antibody profile in benign and malignant gastroduodenal diseases. Gut 1998; 43:182-186.
22. 22 Atherton JC, Peek RM, Tham KT, Cover TL, Blaser MJ. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 1997; 112: 92-99.
23. 23 Ito Y, Azuma T, Ito S, Miyaji H, Hirai M, Yamazaki Y, et al. Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. J Clin Microbiol 1997; 35:1710-1714.
24. 24 Shimoyama T, Yoshimura T, Mikami T, Fukuda S, Crabtree JE, Munakata A. Evaluation of Helicobacter pylori vacA genotype in Japanese patients with gastric cancer. J Clin Pathol 1998; 51:299-301.
25. 25 Forsyth MH, Atherton JC, Blaser MJ, Cover TL. Heterogeneity in levels of vacuolating cytotoxin gene (vacA) transcription among Helicobacter pylori strains. Infect Immun 1998; 66:3088-3094.
26. 26 Pagliaccia C, de Bernard M, Lupetti P, Ji X, Burroni D, Cover TL, et al. The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. Proc Natl Acad Sci USA 1998; 95:10212-10217.